CRIKZO 250MG CAP
Prescription Required
Sale price
₹ 6,500.00
Regular price
MRP: ₹ 7,600.00
14% OFF
Inclusive of all taxes.
Couldn't load pickup availability
CRIKZO 250MG CAP
Regular price
₹ 6,500.00
Regular price
₹ 7,600.00
Sale price
₹ 6,500.00
(-14%)
Unit price
per
CRIKZO 250MG CAP
Sale price
₹ 6,500.00
Regular price
MRP: ₹ 7,600.00
14% OFF
- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Crikzo 250mg Capsule contains crizotinib, a targeted tyrosine kinase inhibitor that blocks ALK, ROS1 and MET pathways involved in cancer cell growth.
Uses
Crikzo 250mg Capsule is used for the treatment of advanced non-small cell lung cancer (NSCLC).
- ALK-positive NSCLC.
- ROS1-positive NSCLC.
Storage
- Store below 30°C in a cool and dry place.
- Protect from moisture and direct sunlight.
Safety Information
- Liver function, vision and heart rhythm should be monitored regularly.
- Inform your doctor about liver disease or heart conditions before treatment.
Possible Side Effects
Possible side effects may include:
- Vision disturbances
- Nausea
- Vomiting
- Diarrhoea
- Oedema
- Fatigue
- Liver enzyme abnormalities
- Slow heart rate
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Crikzo is a prescription targeted anticancer medicine.
It should only be used under the supervision of a qualified oncologist.